About AviGen
AviGen is a company based in Alameda (United States) founded in 1992 was acquired by MediciNova in February 2009. AviGen operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Mereo BioPharma and Serum Institute of India, among others.
- Headquarter Alameda, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
MediciNova
(Feb 09, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AviGen
Detailed funding history for AviGen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AviGen
AviGen has secured backing from 1 investor. Prominent investors backing the company include MediciNova.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases.
|
Locked | Locked | Locked |
Investor details for AviGen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AviGen
Investment portfolio details for AviGen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AviGen
Detailed financials for AviGen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avigen Comparisons
Peer comparison for AviGen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AviGen
AviGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Mereo BioPharma and Serum Institute of India, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
|
| Locked | Locked | Locked |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
Detailed competitors of AviGen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avigen
Complete news archive for AviGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AviGen
AviGen was founded in 1992.
AviGen is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
Founded in 1992 and based in Alameda, United States, operations are focused on biotechnology, specifically gene therapy for diseases such as cancer, anemia, hemophilia, hyperlipidemia, and metabolic storage disorders. Proprietary technologies including AAV vectors and the Targeted Vector Integration system are utilized to deliver genes. Treatments for blood cell-related conditions like sickle cell anemia, beta-thalassemia, and HIV infection are also advanced.
AviGen's top competitors include Moderna, Spark Therapeutics and BridgeBio.
AviGen has 1 investor. Key investors include MediciNova.